EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exosomal circ_0050688 Shapes a Chemoresistant Microenvironment by Driving Spatial Resistance Spreading in Glioblastoma via the MDM2 Pathway

Qiang Li, Jianglong Xu, Yuhao Zhang, Junbing Qian, Diana Bee-Lan Ong, Kein Seong Mun, Yiping Tang, Xiuchao Geng iD, Kean Chang Phang iD

Biomolecules · 18.06.2026 · 16 (6) · 906

DOI: 10.3390/biom16060906 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 18.06.2026. Verfasst von Qiang Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Taizhou University, Taizhou 318000, Zhejiang, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-mdm2, Glioblastoma, Exosomes, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation, Zhejiang Provincial Natural Science Foundation of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acquired tolerance to temozolomide (TMZ) remains one of the main obstacles to enduring therapeutic success in glioblastoma (GBM). While tumor-derived extracellular vesicles are known to orchestrate therapy evasion by horizontally transferring molecules across the tumor microenvironment, the precise regulatory roles of specific exosomal circular RNAs (circRNAs) in establishing this refractory state require further elucidation.

Methods

The expression of circ_0050688 in TMZ-resistant GBM clinical tissues and cell lines was evaluated. Exosomes derived from resistant cells were isolated and confirmed via transmission electron microscopy (TEM) and marker analysis. PKH67 fluorescent tracking was utilized to visually demonstrate exosome internalization by sensitive recipient cells. Biological functions, including the expression of the multidrug resistance protein P-glycoprotein (P-gp) and the proliferation marker Ki-67, were evaluated. The competing endogenous RNA mechanism was validated using RNA FISH, dual-luciferase reporters, and functional rescue experiments. In vivo efficacy was determined using subcutaneous xenograft mouse models.

Results

Clinical and in vitro analyses revealed that circ_0050688 is upregulated in TMZ-refractory GBM, predicting adverse patient survival. Through PKH67-based tracing, we confirmed that resistant cells actively secrete circ_0050688-enriched exosomes, which are subsequently engulfed by drug-sensitive bystander cells. This vesicular transfer directly instigates a chemoresistant and highly proliferative phenotype, marked by elevated P-gp and Ki-67 levels. At the molecular level, circ_0050688 operates as a molecular decoy for miR-508-5p, thereby preventing the suppression of its downstream target, MDM2. Functionally, circ_0050688 depletion eradicated these aggressive traits and restored TMZ vulnerability across both cellular and murine xenograft models. Furthermore, rescue assays confirmed that this circ_0050688-driven chemoresistance is fundamentally dependent on the miR-508-5p/MDM2 signaling axis.

Conclusions

Current data uncover an intercellular signaling network driven by vesicular circ_0050688, which functions as a mobile oncogene to reshape the TMZ-refractory microenvironment. Targeting this exosomal circ_0050688/miR-508-5p/MDM2 network to suppress P-gp and Ki-67 expression represents a highly promising therapeutic strategy for refractory GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-mdm2GlioblastomaExosomesDrug Resistance, NeoplasmTumor MicroenvironmentRNA, CircularBrain NeoplasmsHumansAnimalsTemozolomideMiceCell Line, TumorMice, NudeGene Expression Regulation, NeoplasticCell ProliferationSignal TransductionFemaleXenograft Model Antitumor AssaysMale

Stichwörter der Autor:innen

MDM2acquired chemoresistancecirc_0050688exosomesglioblastoma

Substanzen

Proto-Oncogene Proteins c-mdm2TemozolomideMDM2 protein, humanRNA, Circular

Autor:innen und Institutionen

  • School of Medicine, Taizhou University, Taizhou 318000, Zhejiang, China.
  • Department of Pathology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur 50603, Malaysia.
  • Department of Psychosomatic, Taizhou Second People's Hospital, Affiliated to School of Medicine, Taizhou University, Taizhou 318000, Zhejiang, China.
  • Department of Neurosurgery, Affiliated Hospital of Hebei University, Baoding 071000, Hebei, China.
  • Department of Neurosurgery, Zhejiang Provincial People's Hospital, Affiliated to Hangzhou Medical College, Hangzhou 310014, Zhejiang, China.

ORCID-Profile: Xiuchao Geng, Kean Chang Phang

Förderung

  • Zhejiang Provincial Natural Science Foundation
  • Zhejiang Provincial Natural Science Foundation of China
  • National Natural Science Foundation of China
  • Fundamental Research Grant Scheme, Ministry of Higher Education of Malaysia
  • Natural Science Foundation of Hebei Province
  • General Research Project of the Education Department of Zhejiang Province
  • Zhejiang Provincial Science and Technology Achievement Transformation Project

Zitieren

APA

Li, Q., Xu, J., Zhang, Y., Qian, J., Bee-Lan Ong, D., Mun, K. S., Tang, Y., Geng, X., & Phang, K. C. (2026). Exosomal circ_0050688 Shapes a Chemoresistant Microenvironment by Driving Spatial Resistance Spreading in Glioblastoma via the MDM2 Pathway. Biomolecules, 16(6), 906. https://doi.org/10.3390/biom16060906

Vancouver

Li Q, Xu J, Zhang Y, Qian J, Bee-Lan Ong D, Mun KS, et al. Exosomal circ_0050688 Shapes a Chemoresistant Microenvironment by Driving Spatial Resistance Spreading in Glioblastoma via the MDM2 Pathway. Biomolecules. 2026;16(6):906. doi:10.3390/biom16060906

BibTeX
@article{Li2026,
  author = {Li, Qiang and Xu, Jianglong and Zhang, Yuhao and Qian, Junbing and Bee-Lan Ong, Diana and Mun, Kein Seong and Tang, Yiping and Geng, Xiuchao and Phang, Kean Chang},
  title = {Exosomal circ_0050688 Shapes a Chemoresistant Microenvironment by Driving Spatial Resistance Spreading in Glioblastoma via the MDM2 Pathway},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {906},
  doi = {10.3390/biom16060906}
}
Kostenlos starten →